http://www.xconomy.com/boston/2009/05/27/vertex-starts-pivotal-cf-trials/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:08:02 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2009/05/27/vertex-starts-pivotal-cf-trials/comment-page-1/#comment-66033 Skin Acne-How to Reduce Its Global Impact | Acne Products Thu, 18 Jun 2009 09:14:27 +0000 http://www.xconomy.com/?p=26445#comment-66033 [...] Vertex Starts Pivotal CF Trials (xconomy.com) [...] [...] Vertex Starts Pivotal CF Trials (xconomy.com) [...]

]]> http://www.xconomy.com/boston/2009/05/27/vertex-starts-pivotal-cf-trials/comment-page-1/#comment-60459 Vertex Starts Pivotal CF Trials | Xconomy « Biotech Beach Bum Wed, 27 May 2009 13:47:04 +0000 http://www.xconomy.com/?p=26445#comment-60459 [...] Vertex Starts Pivotal CF Trials | Xconomy Vertex, a Boston-based biotech with offices in San Diego, announces clinical trials of their new Cystic Fibrosis drug. It will be exciting to see how these go.  Cystic Fibrosis, an abnormality to a protein that regulates chloride ions in cells, is one of the most common genetic conditions in our population, and often shows up in business models that monetize gene therapies with the potential to lead to personalized medicine.  http://www.xconomy.com/boston/2009/05/27/vertex-starts-pivotal-cf-trials/ [...] [...] Vertex Starts Pivotal CF Trials | Xconomy Vertex, a Boston-based biotech with offices in San Diego, announces clinical trials of their new Cystic Fibrosis drug. It will be exciting to see how these go.  Cystic Fibrosis, an abnormality to a protein that regulates chloride ions in cells, is one of the most common genetic conditions in our population, and often shows up in business models that monetize gene therapies with the potential to lead to personalized medicine.  http://www.xconomy.com/boston/2009/05/27/vertex-starts-pivotal-cf-trials/ [...]

]]>